Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic
Description
Immunocompromised status and interrupted routine care may render patients with cirrhosis vulnerable to the coronavirus disease 2019 (COVID-19) pandemic. A nationwide dataset that includes more than 99% of the decedents in the U.S. between April 2012
